Archives

Subscribe

Subscribe to Biothera news

Media Contact

David Walsh

Corporate Communications

dwalsh@biotherapharma.com

651-675-0300

 

2007-08 News Releases

 

 

May 8, 2008

Wellmune WGP® Receives Regulatory Approval in Australia

 

May 7, 2008

Robert P. Hill Joins Biothera Board of Directors

 

April 9, 2008

Wellmune Alleviates Severity and ‘Down Time' Due to Cold Symptoms

 

March 19, 2008

Biothera Compounds Induce Immune Responses via Different Mechanisms

 

March 19, 2008

Biothera Responds to Patent Litigation Statements

 

March 10, 2008

Biothera Awarded Patent for New Cancer Therapy

 

February 28, 2008

Biothera Drug Synergistic with Avastin Against Cancer, Study Finds

 

December 7, 2007

Benson Named 'Rising Star' Among Minnesota Lawyers

 

November 6, 2007
Wellmune WGP® Reduces Incidence of Stress-Related Health Challenges

 

November 6, 2007
Wellmune WGP® Reduced Fatigue and Infection Symptoms in Marathoners

 

October 9, 2007

Biothera initiates Phase Ib/IIa clinical trial in cancer patients

 

October 5, 2007

Biothera Recognized as One of Minnesota’s Top Technology Companies

 

September 11, 2007
Imprime PGG Increases Efficacy of Erbitux Against Non-Small Cell Lung Cancer

 

July 29, 2007

Wellmune WGP® Receives 2007 IFT Food Expo Innovation Award

 

July 27, 2007

Biothera and MIT File Patent Infringement Lawsuit Against Biorgin

 

July 26, 2007

Biothera to Introduce Wellmune WGP® at IFT Food Expo

 

June 4, 2007

Imprime PGG Enhanced Effectiveness of Avastin in Cancer Study

 

May 4, 2007
Biothera to Present at BIO International Convention

 

May 1 , 2007

Biothera Compounds Enhance Human Immune Cell Function, Study Finds

 

April 20, 2007

Biothera Achieves ‘Good Laboratory Practice’ Status

 

March 6 , 2007
Vasilakos Joins Biothera as Vice President, Immunology

 


Site design by Checkerboard